Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
ANGLE plc stock logo
ANPCY
ANGLE
C$0.61
C$0.85
C$0.61
C$2.39
N/AN/A1,305 shs33 shs
bioAffinity Technologies, Inc. stock logo
BIAFW
bioAffinity Technologies
$0.10
-1.2%
$0.14
$0.10
$2.90
N/AN/A11,102 shs440 shs
Epigenomics AG stock logo
EPGNY
Epigenomics
$2.39
$2.39
$2.01
$2.39
N/AN/A100 shsN/A
WuXi AppTec Co., Ltd. stock logo
WUXIF
WuXi AppTec
$13.54
+73.3%
$7.46
$3.74
$13.54
N/AN/A1,850 shs310 shs
7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
ANGLE plc stock logo
ANPCY
ANGLE
0.00%-18.52%-0.13%-26.77%-63.84%
bioAffinity Technologies, Inc. stock logo
BIAFW
bioAffinity Technologies
0.00%0.00%-44.87%-10.71%-92.06%
Epigenomics AG stock logo
EPGNY
Epigenomics
0.00%0.00%0.00%0.00%0.00%
WuXi AppTec Co., Ltd. stock logo
WUXIF
WuXi AppTec
+84.43%+84.43%+84.43%+84.43%+261.97%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
ANGLE plc stock logo
ANPCY
ANGLE
N/AN/AN/AN/AN/AN/AN/AN/A
bioAffinity Technologies, Inc. stock logo
BIAFW
bioAffinity Technologies
N/AN/AN/AN/AN/AN/AN/AN/A
Epigenomics AG stock logo
EPGNY
Epigenomics
N/AN/AN/AN/AN/AN/AN/AN/A
WuXi AppTec Co., Ltd. stock logo
WUXIF
WuXi AppTec
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
ANGLE plc stock logo
ANPCY
ANGLE
0.00
N/AN/AN/A
bioAffinity Technologies, Inc. stock logo
BIAFW
bioAffinity Technologies
0.00
N/AN/AN/A
Epigenomics AG stock logo
EPGNY
Epigenomics
0.00
N/AN/AN/A
WuXi AppTec Co., Ltd. stock logo
WUXIF
WuXi AppTec
0.00
N/AN/AN/A
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
ANGLE plc stock logo
ANPCY
ANGLE
N/AN/AN/AN/AN/AN/A
bioAffinity Technologies, Inc. stock logo
BIAFW
bioAffinity Technologies
$8.81MN/AN/AN/AN/AN/A
Epigenomics AG stock logo
EPGNY
Epigenomics
N/AN/AN/AN/AN/AN/A
WuXi AppTec Co., Ltd. stock logo
WUXIF
WuXi AppTec
N/AN/AN/AN/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
ANGLE plc stock logo
ANPCY
ANGLE
N/A-C$0.48N/AN/AN/AN/AN/AN/A
bioAffinity Technologies, Inc. stock logo
BIAFW
bioAffinity Technologies
N/AN/A0.00N/AN/AN/AN/AN/A
Epigenomics AG stock logo
EPGNY
Epigenomics
N/A-$3.05N/AN/AN/AN/AN/AN/A
WuXi AppTec Co., Ltd. stock logo
WUXIF
WuXi AppTec
N/AN/A0.00N/AN/AN/AN/A10/27/2025 (Estimated)
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
ANGLE plc stock logo
ANPCY
ANGLE
N/AN/AN/AN/AN/A
bioAffinity Technologies, Inc. stock logo
BIAFW
bioAffinity Technologies
N/AN/AN/AN/AN/A
Epigenomics AG stock logo
EPGNY
Epigenomics
N/AN/AN/AN/AN/A
WuXi AppTec Co., Ltd. stock logo
WUXIF
WuXi AppTec
N/AN/AN/AN/AN/A

Institutional Ownership

CompanyInstitutional Ownership
ANGLE plc stock logo
ANPCY
ANGLE
N/A
bioAffinity Technologies, Inc. stock logo
BIAFW
bioAffinity Technologies
N/A
Epigenomics AG stock logo
EPGNY
Epigenomics
N/A
WuXi AppTec Co., Ltd. stock logo
WUXIF
WuXi AppTec
N/A

Insider Ownership

CompanyInsider Ownership
ANGLE plc stock logo
ANPCY
ANGLE
N/A
bioAffinity Technologies, Inc. stock logo
BIAFW
bioAffinity Technologies
N/A
Epigenomics AG stock logo
EPGNY
Epigenomics
N/A
WuXi AppTec Co., Ltd. stock logo
WUXIF
WuXi AppTec
N/A
CompanyEmployeesShares OutstandingFree FloatOptionable
ANGLE plc stock logo
ANPCY
ANGLE
173N/AN/ANot Optionable
bioAffinity Technologies, Inc. stock logo
BIAFW
bioAffinity Technologies
10N/AN/ANot Optionable
Epigenomics AG stock logo
EPGNY
Epigenomics
32N/AN/ANot Optionable
WuXi AppTec Co., Ltd. stock logo
WUXIF
WuXi AppTec
41,116N/AN/ANot Optionable

Recent News About These Companies

Wuxi AppTec sees strong profit growth for 1H25

New MarketBeat Followers Over Time

Media Sentiment Over Time

ANGLE stock logo

ANGLE OTCMKTS:ANPCY

C$0.61 0.00 (0.00%)
As of 08/13/2025

ANGLE plc, a medical diagnostic company, engages in developing cancer diagnostics products in Europe, North America, and the United Kingdom. The company develops and commercializes Parsortix cell separation system, which captures and harvests circulating tumor cells in metastatic breast cancer patient blood; and HyCEAD. ANGLE plc has a partnership agreement with Bio View Ltd to develop a liquid biopsy circulating tumor cell HER2 assay for breast cancer. The company was founded in 1994 and is based in Guildford, the United Kingdom.

bioAffinity Technologies stock logo

bioAffinity Technologies NASDAQ:BIAFW

$0.10 0.00 (-1.19%)
As of 08/15/2025 03:47 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

bioAffinity Technologies, Inc., a biotechnology company, engages in developing non-invasive diagnostic tests and targeted cancer therapeutics. The company offers CyPath lung, a diagnostic test, for early detection of lung cancer. It also researches targeted therapies to treat lung cancer and other diseases of the lung at the cellular level. The company was incorporated in 2014 and is based in San Antonio, Texas.

Epigenomics stock logo

Epigenomics OTCMKTS:EPGNY

$2.39 0.00 (0.00%)
As of 04/6/2023

Epigenomics AG, a molecular diagnostics company, focuses on liquid biopsy for the early detection of cancer. Its lead product is Epi proColon, a blood-based test for the early detection of colorectal cancer in the United States, Europe, and China. The company's products also include hepatocellular carcinoma blood test; Epi proColon, a liquid biopsy test for detection of colorectal cancer; and Epi BiSKit, a pre-analytical tool, which provides a set of reagents for the preparation of bisulfite-converted DNA. Its research and development activities identify suitable biomarkers in human tissue and developing and patenting the corresponding in vitro diagnostic blood tests. Epigenomics AG was founded in 1998 and is headquartered in Berlin, Germany.

WuXi AppTec stock logo

WuXi AppTec OTCMKTS:WUXIF

$13.54 +5.73 (+73.34%)
As of 08/15/2025 11:14 AM Eastern

WuXi AppTec Co., Ltd., an investment holding company, provides research, development, and manufacturing services to discover, develop, and manufacture small molecule drugs, and cell and gene therapies in the People's Republic of China, the United States, Europe, and internationally. The company operates through six segments: WuXi Chemistry, WuXi Testing, WuXi Biology, WuXi ATU, WuXi DDSU, and Others. It offers contract research, development, and manufacturing organization services for new drug development from discovery to commercial covering various categories for various synthetic molecular modalities, including small molecules, oligonucleotides, peptides, and complex conjugates; and biology services and solutions that support stand-alone and integrated projects from target discovery to candidate selection and into the clinic. The company also provides seamless drug and medical device testing services from preclinical testing to clinical trials; an integrated end-to-end solution to accelerate time to market for cell and gene therapies; drug discovery services to pharmaceutical and biotech customers; and clinical testing services. WuXi AppTec Co., Ltd. was founded in 2000 and is headquartered in Shanghai, the People's Republic of China.